Kyprolis Interactions
There are 353 drugs known to interact with Kyprolis (carfilzomib), along with 12 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 113 are major, and 240 are moderate.
- View all 353 medications that may interact with Kyprolis
- View Kyprolis alcohol/food interactions (1)
- View Kyprolis disease interactions (12)
Most frequently checked interactions
View interaction reports for Kyprolis (carfilzomib) and the medicines listed below.
- acyclovir
- allopurinol
- amlodipine
- Aspirin Low Strength (aspirin)
- atorvastatin
- Bactrim (sulfamethoxazole / trimethoprim)
- Benadryl (diphenhydramine)
- calcium / vitamin d
- cannabis
- daratumumab
- Darzalex (daratumumab)
- Darzalex Faspro (daratumumab / hyaluronidase)
- dexamethasone
- doxycycline
- Eliquis (apixaban)
- gabapentin
- levofloxacin
- levothyroxine
- lisinopril
- ondansetron
- Pomalyst (pomalidomide)
- prednisone
- Revlimid (lenalidomide)
- Tylenol (acetaminophen)
- Velcade (bortezomib)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
- Xgeva (denosumab)
- Zofran (ondansetron)
- Zometa (zoledronic acid)
Kyprolis alcohol/food interactions
There is 1 alcohol/food interaction with Kyprolis (carfilzomib).
Kyprolis disease interactions
There are 12 disease interactions with Kyprolis (carfilzomib) which include:
- TLS
- cardiac disease
- dyspnea
- hemorrhage
- hepatic toxicity
- hypertension
- PRES
- pulmonary hypertension
- pulmonary toxicity
- renal failure
- TTP/HUS
- venous thrombosis
Report options
QR code containing a link to this page
More about Kyprolis (carfilzomib)
- Kyprolis consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (5)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: proteasome inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
